In cooperation with TLR2, NLRP3 inflammasome activation in cardiac macrophages was also involved in DM-induced, potentially life-threatening arrhythmias, which could be successfully treated by either NLRP3 inflammasome inhibition or IL-1 receptor antagonism [54]. Here, NLRP3 is linked to diabetes mellitus.